Dimensional Fund Advisors
BBIO icon

Dimensional Fund Advisors’s BridgeBio Pharma BBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.2M Sell
596,423
-22,703
-4% -$1.77M 0.01% 1705
2026
Q2 		$46.1M Buy
619,126
+57,181
+10% +$4.01M 0.01% 1639
2026
Q1 		$41.7M Buy
561,945
+179,376
+47% +$13M 0.01% 1596
2025
Q4 		$29.3M Buy
382,569
+314,316
+461% +$20.6M 0.01% 1788
2025
Q3 		$3.55M Sell
68,253
-33,534
-33% -$1.64M ﹤0.01% 2630
2025
Q2 		$4.4M Buy
101,787
+5,305
+5% +$193K ﹤0.01% 2566
2025
Q1 		$3.34M Buy
96,482
+34,817
+56% +$1.17M ﹤0.01% 2607
2024
Q4 		$1.69M Sell
61,665
-1,036
-2% -$26.8K ﹤0.01% 2828
2024
Q3 		$1.6M Sell
62,701
-10,529
-14% -$276K ﹤0.01% 2832
2024
Q2 		$1.85M Buy
73,230
+3,624
+5% +$99.1K ﹤0.01% 2775
2024
Q1 		$2.15M Buy
69,606
+21,977
+46% +$747K ﹤0.01% 2778
2023
Q4 		$1.92M Buy
47,629
+2,234
+5% +$67.1K ﹤0.01% 2798
2023
Q3 		$1.2M Buy
+45,395
New +$1.29M ﹤0.01% 2880
2022
Q1 		– Sell
-31,467
Closed -$525K – 3512
2021
Q4 		$525K Sell
31,467
-154,971
-83% -$6.56M ﹤0.01% 3154
2021
Q3 		$8.74M Buy
186,438
+36,789
+25% +$1.97M ﹤0.01% 2390
2021
Q2 		$9.12M Buy
149,649
+69,143
+86% +$3.95M ﹤0.01% 2407
2021
Q1 		$4.96M Buy
80,506
+47,835
+146% +$3.13M ﹤0.01% 2586
2020
Q4 		$2.32M Buy
+32,671
New +$1.58M ﹤0.01% 2765
2020
Q3 		– Sell
-30,700
Closed -$1M – 3333
2020
Q2 		$1M Sell
30,700
-3,639
-11% -$111K ﹤0.01% 2941
2020
Q1 		$996K Buy
34,339
+26,353
+330% +$817K ﹤0.01% 2893
2019
Q4 		$280K Buy
+7,986
New +$221K ﹤0.01% 3220

Other funds holding BBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors's BBIO Position: Q3 2026 in Review

Dimensional Fund Advisors reduced its BridgeBio Pharma (BBIO) stake by 3.7% in Q3 2026, selling an estimated $1.77M and leaving 596,423 shares worth $39.2M. The position accounts for 0.01% of the portfolio, ranked #1705.

Dimensional Fund Advisors first reported a position in BBIO in Q4 2019 and has held it in 21 quarters since. The position peaked at $46.1M in Q2 2026. 202 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Dimensional Fund Advisors held 596,423 shares of BridgeBio Pharma worth $39.2M as of Q3 2026.
  • Dimensional Fund Advisors sold 22,703 BridgeBio Pharma shares in Q3 2026, an estimated $1.77M.
  • BridgeBio Pharma made up 0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #1705 holding.
  • Dimensional Fund Advisors first reported a position in BridgeBio Pharma in Q4 2019 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's BridgeBio Pharma position peaked at $46.1M in Q2 2026.
  • 202 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.